Literature Archives

While overall diagnostic yield was similar across modalities, TBCB provided significantly higher-quality tissue for molecular profiling assays (P = 0.002) and less crush artifact compared to TBFB (P < 0.0001). Clinicians should consider supplementing EBUS-TBNA with TBFB or TBCB when suspecting inflammatory or lymphoproliferative conditions, or when high-quality tissue is needed for molecular assays.

Understanding healthcare coding, relative value units, and reimbursement principles is essential for interventional pulmonologists to advocate for resources and build a sustainable program. The text does not provide specific numerical results or statistical values.

Although mucosal alterations occurred in 89.2% of procedures, these changes were minor and clinically insignificant, confirming that EUS-B-FNA performed by interventional pulmonologists is safe and feasible without requiring interventions or causing severe events.

Successful pleurodesis is an independent predictor of improved overall survival, with postpleurodesis survival more than 3-times higher in the successful pleurodesis subgroup at P < 0.001, suggesting that definitive pleural interventions go beyond mere symptom palliation.

Flexible bronchoscopy with bronchial forceps achieved a 75% initial retrieval success rate, highlighting an effective approach for clinicians managing aspirated dental objects.

For interventional pulmonologists managing hepatic hydrothorax in patients intolerant to diuretics or ineligible for TIPS, indwelling pleural catheters offer a safe alternative associated with lower odds of emergency room visits (OR 2.273, 95% CI 1.423-3.631 for the serial thoracentesis group).

While 3 or fewer biopsies achieved a 93% diagnostic yield, tailoring the biopsy strategy based on pleural morphology is recommended, especially when comprehensive biomarker testing requires samples beyond the first aliquot.

Linear EBUS-TBNA is a highly effective tool for evaluating ultrasound-visible lung lesions, demonstrating a diagnostic yield of 90.5% and making lung cancer ancillary testing feasible in almost all cases.

The risk of false upstaging without ROSE is small, and preventing a single false upstage requires roughly 250 to 350 extra needle changes in central cN0 cases, suggesting routine needle changes between N2 stations provide minimal benefit for most patients.

Patient height does not impact the success of robotic-assisted bronchoscopy, as r-EBUS localization succeeded in 91.7% of cases with no significant differences across height quartiles (P = 0.95). This demonstrates that patients of smaller stature can undergo the procedure safely without compromised reach or access.

All bronchoscopy procedures exceeded recommended medical sound thresholds of 35 to 45 dB(A), with a median overall level of 56.8 dB(A) (P < 0.0001). Rigid bronchoscopy was associated with higher noise levels, while robotic bronchoscopy was associated with lower noise levels compared to flexible bronchoscopy.

YOLOv8-based system offers real-time bronchial detection and guidance, potentially enhancing procedural precision